Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Suramin

😃Good
Catalog No. T75303Cas No. 145-63-1

Suramin is a dual-function inhibitor of SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) and protein tyrosine phosphatases (PTPases), with antiparasitic, anticancer, and anti-angiogenesis properties, inhibiting sirtuins and DNA topoisomerase II.

Suramin

Suramin

😃Good
Catalog No. T75303Cas No. 145-63-1
Suramin is a dual-function inhibitor of SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) and protein tyrosine phosphatases (PTPases), with antiparasitic, anticancer, and anti-angiogenesis properties, inhibiting sirtuins and DNA topoisomerase II.
Pack SizePriceAvailabilityQuantity
5 mgInquiryBackorder
50 mgInquiryBackorder
Bulk & Custom
Add to Cart
Questions
View More
Select Batch
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Suramin is a dual-function inhibitor of SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) and protein tyrosine phosphatases (PTPases), with antiparasitic, anticancer, and anti-angiogenesis properties, inhibiting sirtuins and DNA topoisomerase II.
Targets&IC50
Topo II:5 μM, SIRT1:297 nM, SIRT5:22 μM, SIRT2:1.15 μM
In vitro
Low concentrations of 35 μM (50 μg/mL) and 70 μM (100 μg/mL) Suramin were not cytotoxic to prefascial adipocytes. However, high concentrations of 105 μM (150 μg/mL) and 140 μM (200 μg/mL) showed cytotoxic effects by reducing cell viability.
Suramin (0-140 μM) stimulated and promoted lipogenic differentiation of FSCs in a time - and dose-dependent manner. [1]
Suramin activates Nrf2 and correspondingly inhibits the activated B cell (NF-κB) nuclear factor kappa light chain enhancer and mitogen-activated protein kinase (MAPK) pathway, thereby reducing IL-1β-stimulated chondrocyte inflammation and ECM degeneration. Suramin repolarizes M1 macrophages to M2 phenotype, further reducing apoptosis of chondrocytes. [2]
In vivo
Rats were intraperitoneally injected with 50 mg/kg Suramin once a week for 4 weeks, and the results showed that Suramin could slightly promote rat adipogenesis in vivo. [1]
Chemical Properties
Molecular Weight1297.28
FormulaC51H40N6O23S6
Cas No.145-63-1
SmilesO=C(NC1=CC=CC(=C1)C(=O)NC2=CC(=CC=C2C)C(=O)NC3=CC=C(C4=CC(=CC(=C34)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)NC5=CC=CC(=C5)C(=O)NC6=CC(=CC=C6C)C(=O)NC7=CC=C(C8=CC(=CC(=C78)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O
Storage & Solubility Information
Storagekeep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Suramin | purchase Suramin | Suramin cost | order Suramin | Suramin chemical structure | Suramin in vivo | Suramin in vitro | Suramin formula | Suramin molecular weight